BI-1182.107

Study Sponsor: Boehringer Ingelheim

Study Title

Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients

Medicine or Vaccine (generic name)

tipranavir

Sponsor Identification Number

1182.107

Trial Registry Identification Number(#'s)

NCT00530920

Medical Condition

HIV Infections

Phase

Phase 2

Link to study details on the BI Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

July 2014